Multiplex imaging reveals the architecture of the tumor immune microenvironment

References

1. 1.↵
   2. Giesen C,
   3. Wang HA,
   4. Schapiro D,
   5. Zivanovic N,
   6. Jacobs A,
   7. Hattendorf B, et al.

   Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Methods. 2014; 11: 417–22.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   2. Goltsev Y,
   3. Samusik N,
   4. Kennedy-Darling J,
   5. Bhate S,
   6. Hale M,
   7. Vazquez G, et al.

   Deep profiling of mouse splenic architecture with CODEX multiplexed imaging. Cell. 2018; 174: 968–81.e15.

   OpenUrlCrossRefPubMed
3. 3.↵
   2. Saka SK,
   3. Wang Y,
   4. Kishi JY,
   5. Zhu A,
   6. Zeng Y,
   7. Xie W, et al.

   Immuno-SABER enables highly multiplexed and amplified protein imaging in tissues. Nat Biotechnol. 2019; 37: 1080–90.

   OpenUrlCrossRefPubMed
4. 4.↵
   2. Angelo M,
   3. Bendall SC,
   4. Finck R,
   5. Hale MB,
   6. Hitzman C,
   7. Borowsky AD, et al.

   Multiplexed ion beam imaging of human breast tumors. Nat Med. 2014; 20: 436–42.

   OpenUrlCrossRefPubMed
5. 5.↵
   2. Wei L,
   3. Chen Z,
   4. Shi L,
   5. Long R,
   6. Anzalone AV,
   7. Zhang L, et al.

   Super-multiplex vibrational imaging. Nature. 2017; 544: 465–70.

   OpenUrlCrossRef
6. 6.↵
   2. Bandura DR,
   3. Baranov VI,
   4. Ornatsky OI,
   5. Antonov A,
   6. Kinach R,
   7. Lou X, et al.

   Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal Chem. 2009; 81: 6813–22.

   OpenUrlCrossRefPubMed
7. 7.↵
   2. Yarilin D,
   3. Xu K,
   4. Turkekul M,
   5. Fan N,
   6. Romin Y,
   7. Fijisawa S, et al.

   Machine-based method for multiplex in situ molecular characterization of tissues by immunofluorescence detection. Sci Rep. 2015; 5: 9534.
8. 8.↵
   2. Liu CQ,
   3. Xu J,
   4. Zhou ZG,
   5. Jin LL,
   6. Yu XJ,
   7. Xiao G, et al.

   Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma. Br J Cancer. 2018; 119: 80–8.

   OpenUrlPubMed
9. 9.↵
   2. Stack EC,
   3. Foukas PG,
   4. Lee PP.

   Multiplexed tissue biomarker imaging. J Immunother Cancer. 2016; 4: 9.

   OpenUrlFREE Full Text
10. 10.↵
    2. Yao Y,
    3. Liu R,
    4. Shin MS,
    5. Trentalange M,
    6. Allore H,
    7. Nassar A, et al.

    CyTOF supports efficient detection of immune cell subsets from small samples. J Immunol Methods. 2014; 415: 1–5.

    OpenUrlCrossRefPubMed
11. 11.↵
    2. Papalexi E,
    3. Satija R.

    Single-cell RNA sequencing to explore immune cell heterogeneity. Nat Rev Immunol. 2018; 18: 35–45.

    OpenUrlPubMed
12. 12.↵
    2. Schapiro D,
    3. Jackson HW,
    4. Raghuraman S,
    5. Fischer JR,
    6. Zanotelli VRT,
    7. Schulz D, et al.

    HistoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data. Nat Methods. 2017; 14: 873–6.

    OpenUrlCrossRefPubMed
13. 13.↵
    2. Ali HR,
    3. Jackson HW,
    4. Zanotelli VRT,
    5. Danenberg E,
    6. Fischer JR,
    7. Bardwell H, et al.

    Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer. Nat Cancer. 2020; 1: 163–75.

    OpenUrl
14. 14.↵
    2. Martinez-Morilla S,
    3. Villarroel-Espindola F,
    4. Wong PF,
    5. Toki MI,
    6. Aung TN,
    7. Pelekanou V, et al.

    Biomarker discovery in patients with immunotherapy-treated melanoma with imaging mass cytometry. Clin Cancer Res. 2021; 27: 1987–96.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    2. Zheng C,
    3. Zheng L,
    4. Yoo JK,
    5. Guo H,
    6. Zhang Y,
    7. Guo X, et al.

    Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell. 2017; 169: 1342–56.e16.

    OpenUrlCrossRefPubMed
16. 16.↵
    2. Forner A,
    3. Reig M,
    4. Bruix J.

    Hepatocellular carcinoma. Lancet. 2018; 391: 1301–14.

    OpenUrlCrossRefPubMed
17. 17.↵
    2. Sheng J,
    3. Zhang J,
    4. Wang L,
    5. Tano V,
    6. Tang J,
    7. Wang X, et al.

    Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny. Gut. 2021; 0: 1–16.
18. 18.↵
    2. Schurch CM,
    3. Bhate SS,
    4. Barlow GL,
    5. Phillips DJ,
    6. Noti L,
    7. Zlobec I, et al.

    Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front. Cell. 2020; 182: 1341–59.e19.

    OpenUrlCrossRefPubMed
19. 19.↵
    2. Erwig M.

    The graph Voronoi diagram with applications. Networks. 2000; 36: 156–63.

    OpenUrl
20. 20.↵
    2. Giuliano AE,
    3. Connolly JL,
    4. Edge SB,
    5. Mittendorf EA,
    6. Rugo HS,
    7. Solin LJ, et al.

    Breast cancer – major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017; 67: 290–303.

    OpenUrlCrossRef
21. 21.↵
    2. Jackson HW,
    3. Fischer JR,
    4. Zanotelli VRT,
    5. Ali HR,
    6. Mechera R,
    7. Soysal SD, et al.

    The single-cell pathology landscape of breast cancer. Nature. 2020; 578: 615–20.

    OpenUrlPubMed
22. 22.↵
    2. Gide TN,
    3. Quek C,
    4. Menzies AM,
    5. Tasker AT,
    6. Shang P,
    7. Holst J, et al.

    Distinct immune cell populations define response to Anti-PD-1 monotherapy and Anti-PD-1/Anti-CTLA-4 combined therapy. Cancer Cell. 2019; 35: 238–55.e6.

    OpenUrlCrossRefPubMed
23. 23.↵
    2. Steele NG,
    3. Carpenter ES,
    4. Kemp SB,
    5. Sirihorachai V,
    6. The S,
    7. Delrosario L, et al.

    Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer. Nat Cancer. 2020; 1: 1097–112.

    OpenUrlPubMed